On-Demand Videos

Dr. Melissa Martinez-Adorno, an award-winning Obstetrician Gynecologist, discusses current CDC... Show more
Dr. Melissa Martinez-Adorno, an award-winning Obstetrician Gynecologist, discusses current CDC guidelines on clinical practices in the U.S. for Mycoplasma genitalium and reviews case studies that highlight how to improve patient care through established screening guidelines. Learn more about Dr. Martinez-Adorno.
Dr. Tonya Chaffee, Clinical Professor, Pediatrics UCSF, discusses the increasing rate of Sexually... Show more
Dr. Tonya Chaffee, Clinical Professor, Pediatrics UCSF, discusses the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population and reviews case studies that highlight how to address STIs in young people. She also educates on the importance of Opt-Out screening as the most effective strategy to reduce STI prevalence in this on-demand webinar. Learn more about Dr. Chaffee.
During this presentation, Dr. Salika Shakir, PhD D(ABMM), will discuss vaginitis, a leading reason... Show more
During this presentation, Dr. Salika Shakir, PhD D(ABMM), will discuss vaginitis, a leading reason for OB/GYN visits.1,2 Upon completion of this program, attendees will be able to: Define vaginitis and its associated health consequences Describe the common causes of vaginitis including bacterial vaginosis, candida vaginitis and Trichomonas vaginalis Compare the typical methods for diagnosing vaginitis including wet prep, Amsel, gram stain with Nugent, direct probe, yeast culture and nucleic acid amplification testing (NAAT) Explain the reasons for using NAAT to diagnose vaginitis Outline the treatment options for the common causes of vaginitis Dr. Shakir was paid an honorarium by Hologic, Inc.  Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.   Kent HL. Epidemiology of Vaginitis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1168-76. ACOG Vaginitis Frequently Asked Questions.  Updated September 2023.  Accessed January 24, 2024. 
Millions of women each year are affected by vaginitis infections, and they are at increased risk... Show more
Millions of women each year are affected by vaginitis infections, and they are at increased risk for sexually transmitted infections (STIs). Join Dr. Jane Schwebke in a discussion on co-infection with STIs and vaginitis. The discussion will review recently published literature and study data that highlights STI distribution among women with symptoms of vaginitis, single and multiple infection rates in women with vaginitis, and STI prevalence of women with clinician and lab diagnosed bacterial vaginosis. The impact of misdiagnosis will be examined as well as the accuracy of vaginitis diagnosis with molecular diagnostics. Learn more about Dr. Schwebke. Dr. Schwebke is a paid consultant of Hologic.  Views and opinions expressed in this video are those of the speaker and do not necessarily represent the views or opinions of Hologic, Inc.
In observance of Sexual Health Month, the Infectious Disease Society of America Foundation (IDSAF)... Show more
In observance of Sexual Health Month, the Infectious Disease Society of America Foundation (IDSAF) hosted a webinar to a discuss Mycoplasma genitalium (M. gen) – the next installment in their Dr. John G. Bartlett Memorial Education Series. Two specialists in the areas of infectious diseases and obstetrics and gynecology explored the various aspects of M. gen, including its epidemiology, testing methods and treatment options. Our experts provided valuable insights into M. gen, its health implications and the measures we can take to address this under-recognized STI. Learning Objectives: Explore the impact of M. gen on sexual health. Assess the epidemiology of M. gen and identify individuals who are at a higher risk of contracting the infection and complications associated with untreated M. gen infections. Examine the testing methods currently available for the detection of M. gen. Describe the treatment options that exist for M. gen infections and investigate the emergence of drug-resistant strains of M. gen and its implications. Review preventive measures and safe sexual practices that individuals can adopt to reduce the risk of M. gen infections. Hologic sponsored this webinar, which was planned and hosted by IDSAF.  Dr. Irene Stafford is a paid consultant of Hologic.  Views and opinions expressed in this video are those of the speakers and do not necessarily represent the views or opinions of Hologic, Inc.
Watch Drs. Tonya Chaffee and Irene Stafford discuss the increasing rate of Sexually Transmitted... Show more
Watch Drs. Tonya Chaffee and Irene Stafford discuss the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population. The following topics will be addressed: the importance of opt-out screening as the most effective strategy to reduce STI prevalence in chlamydia and gonorrhea and real-world data reflective of current clinical practices in the U.S. for Mycoplasma genitalium and ways to improve patient care through established testing guidelines. LEARN ABOUT DR. CHAFFEE AND DR. STAFFORD.
During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent... Show more
During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent and often misdiagnosed STI, will be discussed. Upon completion of this video, viewers will be able to: Describe M. gen and why it is challenging to diagnose Explain the clinical presentation of M. gen and its associated health consequences Summarize the prevalence of M. gen State the CDC guidelines for M. gen testing Outline the treatment options for M. gen depending on the availability of resistance testing Compare RNA and DNA-based tests for M. gen detection LEARN MORE ABOUT THE SPEAKER
Mycoplasma genitalium infections present unique challenges from a treatment perspective. Proper... Show more
Mycoplasma genitalium infections present unique challenges from a treatment perspective. Proper diagnosis is important to drive the right treatment decisions. Hear from clinical experts, Dr. William M. Geisler and Dr. Barbara Van Der Pol, as they discuss complex cases of this STI and provide clinical recommendations for treatment options. LEARN MORE ABOUT DR. GEISLER LEARN MORE ABOUT DR. VAN DER POL
Join Dr. Jamie Shutter and Dr. Melissa Maxwell-Stropes as they discuss the latest CDC... Show more
Join Dr. Jamie Shutter and Dr. Melissa Maxwell-Stropes as they discuss the latest CDC recommendations for Mycoplasma genitalium testing and the importance of utilizing rRNA-based NAAT (Nucleic Acid Amplification Testing). LEARN MORE ABOUT THE SPEAKER